Overview

• CEO Stephen Gillett told employees in an August 26 memo that layoffs were made across the company to concentrate resources on top priorities, with the number of affected staff not disclosed.
• Verily is fully winding down its Devices program and will discontinue manufacturing and support for medical devices going forward.
• The company will continue to support the Numetric Watch only for customers in active clinical trials to meet existing commitments.
• The Devices organization previously worked on efforts including the Dexcom G7 continuous glucose monitor partnership, retinal imaging tools, clinical study wearables, and the Stargazer VNRC study.
• A spokesperson said the changes reflect deliberate resourcing to speed a path to sustained commercial success, following earlier streamlining that included selling the insurance business to Elevance Health this year.